REQUEST A DEMO
Total
USD $0.00
Search more companies

Terapeutica Boliviana S.A. (Bolivia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Terapeutica Boliviana S.A. Profile Updated: March 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Terapeutica Boliviana S.A. is based in Bolivia. The head office is in Santa Cruz de la Sierra. It operates in the Pharmaceutical Preparation Manufacturing industry. Terapeutica Boliviana S.A. was incorporated on 1979. There are currently 360 (estimated) people employed by Terapeutica Boliviana S.A.. The latest financial highlights indicate a net sales revenue drop of 27.76% in 2023. Its’ total assets recorded a negative growth of 14.92%.

Headquarters
Barrio Hamacas Calle 2 Este Entre Calles: Calle Poresaqui No3205 Edificio: S/N Piso: S/N Oficina: S/N Zona: Norte
Santa Cruz de la Sierra; Santa Cruz de la Sierra;

Contact Details: Purchase the Terapeutica Boliviana S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Terapeutica Boliviana S.A. report to view the information.
Outstanding Shares:
Purchase the Terapeutica Boliviana S.A. report to view the information.
Financial Auditors:
Purchase the Terapeutica Boliviana S.A. report to view the information.
Incorporation Date:
1979
Key Executives
Purchase this report to view the information.
President
Company Performance
Financial values in the chart are available after Terapeutica Boliviana S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BOB. Absolute financial data is included in the purchased report.
Net sales revenue
-27.76%
Total operating revenue
-27.76%
Operating profit (EBIT)
-67.67%
Net Profit (Loss) for the Period
N/A
Total assets
-14.92%
Total equity
-42.74%
Operating Profit Margin (ROS)
-7.85%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
160.03%
Quick Ratio
0.73%
Cash Ratio
0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?